Statistics for TBCRC 019: A phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with triple negative breast cancer
Total visits
| views | |
|---|---|
| TBCRC 019: A phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with triple negative breast cancer | 434 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| Forero-Torres_2015_tbcrc.pdf | 507 |
| java.util.UUID:d824a708-25a1-45da-84d3-dd93f6f3d023 | 15 |
| java.util.UUID:6956b0ca-fe2a-45f2-ac3a-26e8aaf799cd | 2 |
| java.util.UUID:b3481fc5-16d0-45f0-8dfa-c9a64ddba572 | 1 |
Top country views
| views | |
|---|---|
| United States | 246 |
| Germany | 55 |
| China | 33 |
| United Kingdom | 11 |
| Russia | 7 |
| Taiwan | 6 |
| Canada | 5 |
| Ukraine | 5 |
| Switzerland | 2 |
| Egypt | 2 |
| India | 2 |
| Italy | 2 |
| Japan | 2 |
| Argentina | 1 |
| Denmark | 1 |
| France | 1 |
| Hong Kong SAR China | 1 |
| South Korea | 1 |
| Malaysia | 1 |
| Netherlands | 1 |
| New Zealand | 1 |
| Poland | 1 |
| Romania | 1 |
| Slovakia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 64 |
| Kiez | 31 |
| Fairfield | 30 |
| Houston | 17 |
| Ann Arbor | 15 |
| Washington | 12 |
| Cambridge | 10 |
| Gunzenhausen | 9 |
| Beijing | 7 |
| Jacksonville | 7 |
| Nürnberg | 7 |
| White Plains | 6 |
| Kiev | 5 |
| Kansas City | 4 |
| Lake Mary | 4 |
| Munich | 4 |
| Rockville | 4 |
| Atlanta | 3 |
| Hangzhou | 3 |
| Hsinchu | 3 |
| Moscow | 3 |
| Mount Laurel | 3 |
| Saint Petersburg | 3 |
| Seattle | 3 |
| Toronto | 3 |
| Endingen | 2 |
| Harbin | 2 |
| Indianapolis | 2 |
| Macclesfield | 2 |
| Philadelphia | 2 |
| San Francisco | 2 |
| Shenzhen | 2 |
| Taipei | 2 |
| York | 2 |
| Abingdon | 1 |
| Alexandria | 1 |
| Arlington | 1 |
| Assiut | 1 |
| Barnet | 1 |
| Belfast | 1 |
| Bethesda | 1 |
| Bialystok | 1 |
| Birmingham | 1 |
| Bucharest | 1 |
| Buenos Aires | 1 |
| Burnaby | 1 |
| Central District | 1 |
| Chongqing | 1 |
| Concord | 1 |
| Dijon | 1 |
| Dmitrov | 1 |
| Falls Church | 1 |
| Guangzhou | 1 |
| Gîza | 1 |
| Herndon | 1 |
| Huntsville | 1 |
| Irvine | 1 |
| Ithaca | 1 |
| Lake Forest | 1 |
| Langfang | 1 |
| Louisville | 1 |
| Milan | 1 |
| Nanning | 1 |
| Novokuznetsk | 1 |
| Providence | 1 |
| San Antonio | 1 |
| Scottsdale | 1 |
| Seremban | 1 |
| Shanghai | 1 |
| Shenyang | 1 |
| Surat | 1 |
| Utrecht | 1 |
| Waltham | 1 |
| Wellington | 1 |
| Wuhan | 1 |
| Ålborg | 1 |